Cytotoxic T-lymphocyte-associated antigen 4 antibody-induced colitis and its management with infliximab. (Q53428689)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 December 2008

Language	Label	Description	Also known as
English	Cytotoxic T-lymphocyte-associated antigen 4 antibody-induced colitis and its management with infliximab.	scientific article published on 23 December 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19104936

Cytotoxic T-lymphocyte-associated antigen 4 antibody-induced colitis and its management with infliximab. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19104936

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

R L Johnston

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19104936

J Lutzky

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19104936

A Chodhry

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19104936

J S Barkin

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19104936

publication date

23 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19104936

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19104936

54

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19104936

11

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19104936

2538-2540

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19104936

Activity and safety of CTLA-4 blockade combined with vaccines in cynomolgus macaques

1 reference

https://api.crossref.org/works/10.1007/S10620-008-0641-Z

21 January 2018

Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4

1 reference

https://pubmed.ncbi.nlm.nih.gov/19104936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19104936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19104936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of CTLA-4 in the regulation and initiation of T-cell responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/19104936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19104936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19104936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CTLA-4 can function as a negative regulator of T cell activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19104936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19104936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19104936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19104936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-008-0641-Z

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19104936

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19104936

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53428689&oldid=2246396062"